United States Medical Licensing Examination

The United States Medical Licensing Examination (USMLE) is a three-step examination program for medical licensure in the United States, sponsored by the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME).<ref>Template:Cite web</ref> Individuals with a Doctor of Medicine (MD) degree are required to pass the USMLE for medical licensure. Those with a Doctor of Osteopathic Medicine degree (DO) may take either the COMLEX-USA or the USMLE for medical licensure, while the COMLEX-USA is required for osteopathic licensure.<ref name = fmsb>Template:Cite web</ref><ref>Template:Cite journal</ref>

States may enact additional testing and/or licensing requirements.<ref>Template:Cite web</ref>

History

The USMLE was created in the early 1990s.<ref name="Chaudhry2020">Template:Cite journal</ref> The program replaced the multiple examinations, including the National Board of Medical Examiners Part Examination program and the Federation of State Medical Boards Federation Licensing Examination (FLEX) program, that offered paths to medical licensing in the medical profession.<ref name="Haist2013">Template:Cite journal</ref>

The examination was originally imparted using pencil and paper. In 1999, computerized examination delivery was included.<ref name="Haist2013" />

In 2004, an examination with standardized patients to assess clinical-skills was added to Step 2 of the USMLE (Step 2 Clinical Skills), and required for licensure beginning with the medical school graduating class of 2005.<ref>Template:Cite journal</ref> During the COVID-19 pandemic, USMLE Step 2CS was initially suspended and later discontinued.<ref>Template:Cite web</ref>

A review of the program was enacted in 2009. USMLE claimed it was done with the intention of orienting the examination to support the licensing decisions made by medical boards, transitioning the exam to a competencies schema and emphasizing the importance of scientific foundations of medicine throughout the examination sequence. They also aimed to continue the assessment of clinical skill and interpretation of clinical information.<ref name="Haist2013" />

USMLE announced a move to a pass/fail model on February 12, 2020, along with other changes. They claimed this was done in an attempt by the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME) to balance focus between exams and actual coursework. The change became effective in 2022.<ref>Template:Cite web</ref><ref name="Chaudhry2020" />

Description and purpose

The United States Medical Licensing Examination (USMLE) is required for medical licensure in the United States by all graduates of M.D.-granting American medical schools as well as all graduates of international medical schools.<ref name="Haist2013" /> It consists of three examinations:<ref name="Cangialosi2021">Template:Cite journal</ref>

• Step 1: Assesses foundational medical science typically obtained during the first two years of medical school
• Step 2CK: Evaluates the applicant's knowledge of clinical medicine
• Step 3: Assesses the application of clinical knowledge to patient management

Previously, USMLE included a clinical skills portion called USMLE Step 2 Clinical Skills. It was discontinued during the COVID-19 pandemic.<ref name="Rajesh2021">Template:Cite journal</ref>

Step 1 and 2 are typically completed by U.S. medical students during medical school, while Step 3 is usually taken by the end of the first year of residency.<ref name="DeZee2012">Template:Cite journal</ref> While the USMLE Step 1 and Step 2 CK exams can be taken at Prometric test centers worldwide, the Step 3 can only be taken in the United States.<ref>Template:Cite web</ref>Template:Citation needed

The USMLE is sponsored by the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME).<ref name="Bernstein2016">Template:Cite journal</ref> They developed it originally to provide state medical boards in the United States with a common examination for all licensure applicants.<ref name="Chaudhry2020" /><ref>Template:Cite journal</ref> However, over time it has also been extensively used by residency programs to predict residency performance and screen residents for selection during the National Resident Matching Program.<ref>Template:Cite journal</ref><ref name="Cangialosi2021" />

Even though it was estimated that at least 60% of osteopathic medical students took at least one USMLE exam in 2020, physicians with D.O. degree are not required to take the USMLE for licensure or graduation. They are licensed as physicians by passing Parts I, II, and III of the COMLEX examination from the National Board of Osteopathic Medical Examiners.<ref>Template:Cite journal</ref>

Eligibility

As of 2024, to be eligible for the United States Medical Licensing Examination (USMLE), candidates must meet specific criteria based on the step of the exam they are applying for:

Step 1 and Step 2 CK:

Candidates must fall into one of the following categories at the time of application and on the day of the examination:

• Medical Students or Graduates of U.S. or Canadian MD Programs:
  • Must be officially enrolled in, or a graduate of, a U.S. or Canadian medical school program leading to the MD degree, accredited by the Liaison Committee on Medical Education (LCME).
• Medical Students or Graduates of U.S. DO Programs:
  • Must be officially enrolled in, or a graduate of, a U.S. medical school program leading to the DO degree, accredited by the Commission on Osteopathic College Accreditation (COCA).
• Medical Students or Graduates of International Medical Schools:
  • Must be officially enrolled in, or a graduate of, a medical school outside the U.S. and Canada that is listed in the World Directory of Medical Schools as meeting the Educational Commission for Foreign Medical Graduates (ECFMG) eligibility requirements, and must meet all other eligibility criteria of the ECFMG.

Step 3:

To be eligible for Step 3, candidates must:

• Have Passed Step 1 and Step 2 CK:
  • Successfully obtain passing scores on both Step 1 and Step 2 CK.
• Hold an MD or DO Degree:
  • Possess an MD or DO degree from an LCME- or COCA-accredited U.S. or Canadian medical school, or an equivalent MD degree from an international medical school listed in the World Directory of Medical Schools that meets ECFMG eligibility requirements and obtain ECFMG Certification.
• Meet Additional Criteria:
  • Fulfill all other eligibility requirements as outlined in the USMLE Bulletin of Information.

The USMLE program also recommends that applicants for Step 3 have completed, or be near completion of, at least one year of postgraduate training in an accredited U.S. graduate medical education program that satisfies state board licensing requirements.<ref>Template:Cite web</ref>

Pass rates by exam

Overall pass rates for the individual Step exams that comprise the USMLE<ref>Template:Cite web</ref>

	Years of data	U.S. M.D. medical school examinees	(US 1st-time takers)	U.S. D.O. medical school examinees	(US DO 1st time)	Examinees from Non-US/Canadian Schools	(Int'l 1st time)
Step 1	(2021)	95%	96%	94%	94%	77%	82%
Step 2 CK	(2020-2021)	98%	99%	98%	98%	88%	91%
Step 3	(2021)	97%	98%	97%	97%	87%	91%

Controversies

USMLE response to COVID-19

The USMLE was met with criticism for their lack of adaptability during the COVID-19 pandemic. The criticism was two-fold: First, for the mishandling and poor communication of exam cancellations by both USMLE program administrators and the third-party exam administrator, Prometric. Second, the pandemic crisis exacerbated existing resentment towards the high-stakes nature of the exam: namely, several students and physicians were upset that the USMLE refused to move up the 2022 deadline of making Step 1 into a pass or fail exam.<ref name="AMADelays">Template:Cite web</ref><ref>Template:Cite web</ref><ref name="MediscapeTestingChaos">Template:Cite web</ref><ref name="UpsetStudents">Template:Cite web</ref>

Racial differences in outcome associated with the use of USMLE Step 1 scores to grant residency interviews

A study conducted in 2020 showed differences in USMLE Step 1 scores attributable to race and ethnicity, with lower mean scores for self-identified Black, Asian, and Hispanic examinees when compared with self-identified White examinees. The mean effect was larger when comparing Caucasian applicants (223) with Black and Hispanic applicants (216).<ref>Template:Cite journal</ref> Depending on the threshold score, an African American was 3–6x less likely to be offered an interview."<ref name="Edmond Deschenes Eckler Wenzel 2001">Template:Cite journal</ref> "61% of minority applicants were accepted into an orthopaedic residency versus 73% of White applicants. White and Asian applicants and residents had higher USMLE Step 1. White applicants and matriculated candidates had higher odds of Alpha Omega Alpha membership compared with Black, Hispanic, and other groups.<ref>Template:Cite journal</ref><ref>Template:Cite web</ref><ref>Template:Cite news</ref><ref>Template:Cite web</ref> In 2020, the American Academy of Family Physicians and the Association of American Medical Colleges expressed their support for changing Step 1 to pass or fail, in part to reduce racial bias.<ref>Template:Cite web</ref><ref>Template:Cite web</ref><ref name="Edmond Deschenes Eckler Wenzel 2001"/>

Financial considerations

The US Medical Licensing Examinations have received criticism due to their high cost. As of 2023, the USMLE charges (in U.S. dollars):

• $660 for Step 1 for US/Canada students (increasing to $670 in 2024),<ref name="nbme.org">Template:Cite web</ref> $1,000 for International medical graduates (IMGs)<ref name="ecfmg.org">Template:Cite web</ref>
• $660 for Step 2 CK for US/Canada students (increasing to $670 in 2024),<ref name="nbme.org"/> $1,000 for IMGs<ref name="ecfmg.org"/>
• $935 for Step 3 for all students<ref>Template:Cite web</ref>

As part of a broader public plea for systemic changes to the improper use of USMLE exams, STAT wrote that this "multimillion-dollar industry has exploited the opportunity to extract thousands of dollars from already overly indebted students. Registering for STEP exams test cost $645–1300, while Step preparation materials and courses run much higher."<ref>Template:Cite web</ref>

Similar exams

• The "Comprehensive Osteopathic Medical Licensing Examination" (COMLEX-USA) is required for osteopathic physicians in the United States

In other countries

• Ärztliche Prüfungen, overseen by the IMPP, in Germany
• Australian Medical Council (AMC) examinations in Australia.
• Examen Nacional de Aspirantes a Residencias Médicas (ENARM) in Mexico
• Épreuves classantes nationales ECNi in France
• Hong Kong Medical Licensing Examination (HKMLE) in Hong Kong.
• Examination for Provisional Registration (EPR) in Malaysia.
• Medical Council of Canada Qualifying Examination, in Canada
• Pakistan Medical and Dental Council NEB and NLE Exam, Pakistan
• Medical Council of India (MCI-FMGE conducted by National Board of Examinations)
• National Eligibility and Entrance Test, India (UG and PG)
• Nepal Medical Council, in Nepal.
• National Examination for Medical Practitioners in Japan
• Professional and Linguistic Assessments Board test (similar exam used in United Kingdom)
• Saudi Medical Licensing Examination (SMLE) in Saudi Arabia<ref>Template:Cite web</ref>
• Ujian Kompetensi Dokter Indonesia (UKDI) Indonesian Doctor Competence Examination, in Indonesia.
• Bahrain Medical Licensure Examination (BLME) in Bahrain.<ref>Template:Cite web</ref>
• Kunskapsprov för läkare, overseen by Umeå University, in Sweden.<ref>Template:Cite web

</ref>

External links

• Template:Official website
• For international medical graduates